Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Gary C. Steven"'
Autor:
Mark S, Dykewicz, Dana V, Wallace, David J, Amrol, Fuad M, Baroody, Jonathan A, Bernstein, Timothy J, Craig, Chitra, Dinakar, Anne K, Ellis, Ira, Finegold, David B K, Golden, Matthew J, Greenhawt, John B, Hagan, Caroline C, Horner, David A, Khan, David M, Lang, Desiree E S, Larenas-Linnemann, Jay A, Lieberman, Eli O, Meltzer, John J, Oppenheimer, Matthew A, Rank, Marcus S, Shaker, Jeffrey L, Shaw, Gary C, Steven, David R, Stukus, Julie, Wang
Publikováno v:
Journal of Allergy and Clinical Immunology. 146:721-767
This comprehensive practice parameter for allergic rhinitis (AR) and nonallergic rhinitis (NAR) provides updated guidance on diagnosis, assessment, selection of monotherapy and combination pharmacologic options, and allergen immunotherapy for AR. New
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::193426b9c3bc51bca73283ecbfdd4b45
https://doi.org/10.1016/j.jaci.2020.07.007
https://doi.org/10.1016/j.jaci.2020.07.007
Autor:
Bruce G. Bender, Tonya Winders, Gary C. Steven, Don A. Bukstein, Michael S. Blaiss, Eli O. Meltzer
Publikováno v:
Annals of Allergy, Asthma & Immunology. 122:463-470
Objective Shared decision making (SDM) is becoming more commonly appreciated and used in medical practice as a way to empower patients who are facing treatment preference-sensitive conditions, such as allergic rhinitis, atopic dermatitis, food allerg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500d173c105a448dc1b238cbd8a8693c
https://doi.org/10.1016/j.anai.2018.08.019
https://doi.org/10.1016/j.anai.2018.08.019
Autor:
Gary C, Steven
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 125(3)
To review what is known about the importance of shared decision making (SDM) in allergic rhinitis.MEDLINE and PubMed database searches for SDM, patient preferences, patient motivation with mobile apps, over-the-counter medications, adherence, complem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5d1c375e97ef783f750a22e1e41e37a
https://pubmed.ncbi.nlm.nih.gov/32615266
https://pubmed.ncbi.nlm.nih.gov/32615266
Autor:
Lorcan P McGarvey, Zhi Jin Xu, Vivek Iyer, James Krainson, James H. Hull, Mark H Gotfried, Jaclyn A Smith, David Muccino, Gary C Steven, Douglas McQuaid, David I. Bernstein, Gregory Daniel Brooks, David Elkayam, Wen-Chi Wu, Selwyn Spangenthal, Mandel R Sher, Jaclyn A. Smith, Yu-Ping Li, John J Condemi, Ellen R Sher, John R Holcomb, W. Carr, Gary N Gross, SM Parker, Gary D Berman, Ratko Djukanovic, Thomas B. Casale, Jason H Friesen, Krishna Sundar, Christopher E. Brightling, Michael Denenberg, Neil Ettinger, S S Birring, Faisal Alfonso Fakih, Bruce M Prenner, Lorcan McGarvey, Niran J Amar, Jonathan Corren, Tim Harrison, Shaila U Gogate, William W. Storms, Alyn H. Morice, Iftikhar Hussain, Leon S Greos, Anthony Montanaro, Anthony P. Ford, James S Good, Eric J Schenkel, Surinder S. Birring, Thomas R Murphy, Michael S Kaplan, William R Lumry, Jonathan Matz, Michael M. Kitt, Mandel Sher, Alan B Goldsobel, Ian D. Pavord
Publikováno v:
Protocol 012 Investigators 2020, ' Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial ', The Lancet Respiratory Medicine . https://doi.org/10.1016/S2213-2600(19)30471-0
BACKGROUND: Gefapixant is a P2X3 receptor antagonist that has shown promise for the treatment of refractory and unexplained chronic cough. The aim of this study was to evaluate the efficacy of gefapixant compared with placebo after 12 weeks of treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bed8062bd34a8ad548083ad97ee59fbd
https://pure.qub.ac.uk/en/publications/gefapixant-a-p2x3-receptor-antagonist-for-the-treatment-of-refractory-or-unexplained-chronic-cough-a-randomised-doubleblind-controlled-parallelgroup-phase-2b-trial(5aa94b05-a819-433a-a265-b0ce6c143476).html
https://pure.qub.ac.uk/en/publications/gefapixant-a-p2x3-receptor-antagonist-for-the-treatment-of-refractory-or-unexplained-chronic-cough-a-randomised-doubleblind-controlled-parallelgroup-phase-2b-trial(5aa94b05-a819-433a-a265-b0ce6c143476).html
Autor:
Dykewicz, Mark S., Wallace, Dana V., Amrol, David J., Baroody, Fuad M., Bernstein, Jonathan A., Craig, Timothy J., Dinakar, Chitra, Ellis, Anne K., Finegold, Ira, Golden, David B.K., Greenhawt, Matthew J., Hagan, John B., Horner, Caroline C., Khan, David A., Lang, David M., Larenas-Linnemann, Desiree E.S., Lieberman, Jay A., Meltzer, Eli O., Oppenheimer, John J., Rank, Matthew A., Shaker, Marcus S., Shaw, Jeffrey L., Steven, Gary C., Stukus, David R., Wang, Julie
Publikováno v:
In The Journal of Allergy and Clinical Immunology October 2020 146(4):721-767
Publikováno v:
Milwaukee Magazine; May2024, Vol. 49 Issue 5, p63-80, 10p
Autor:
ABRAMSON, ASHLEY
Publikováno v:
Milwaukee Magazine; May2023, Issue 5, p65-82, 10p, 1 Color Photograph
Autor:
ABRAMSON, ASHLEY
Publikováno v:
Milwaukee Magazine; May2022, Vol. 47 Issue 5, p39-64, 18p, 6 Color Photographs, 2 Black and White Photographs, 2 Cartoon or Caricatures
Publikováno v:
Milwaukee Magazine; May2020, Vol. 45 Issue 5, p43-59, 10p
Autor:
Hershenov, Rose, Doroski, Derek
Publikováno v:
Theoretical Medicine & Bioethics; Aug2018, Vol. 39 Issue 4, p301-319, 19p